Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Haleon PLC Sponsored ADR ( (HLN) ) is now available.
On August 22, 2025, Haleon PLC announced the purchase and cancellation of 175,642 ordinary shares as part of its share buyback program initiated on July 31, 2025. This transaction, executed on August 21, 2025, reflects Haleon’s strategic financial management to optimize its capital structure and enhance shareholder value. Following this buyback, the company’s registered share capital stands at 8,970,696,108 ordinary shares, with 8,966,815,903 shares holding voting rights. This move may influence stakeholder decisions, particularly regarding interest notifications under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (HLN) stock is a Hold with a $11.00 price target. To see the full list of analyst forecasts on Haleon PLC Sponsored ADR stock, see the HLN Stock Forecast page.
Spark’s Take on HLN Stock
According to Spark, TipRanks’ AI Analyst, HLN is a Neutral.
Haleon PLC’s overall stock score reflects a strong financial foundation with robust cash flow and profitability margins. However, technical indicators suggest caution due to potential short-term weakness. The valuation is moderate, and while the earnings call showed confidence in international markets, challenges in North America remain a concern. The company’s ability to navigate these challenges and maintain growth will be crucial for future performance.
To see Spark’s full report on HLN stock, click here.
More about Haleon PLC Sponsored ADR
Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with a human touch. The company’s product portfolio includes Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Haleon is known for its trusted brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren.
Average Trading Volume: 13,117,865
Technical Sentiment Signal: Buy
Current Market Cap: $43.53B
See more insights into HLN stock on TipRanks’ Stock Analysis page.